Table 2 The most common adverse events (AEs) during sunitinib therapy in the entire analyzed group of GIST patients

Any treatment-related AE

127

92.7

43

31.4

Fatigue

89

65

12

8.7

Diarrhea

37

28

4

2.9

Hand-foot syndrome

55

40

3

2.2

Decreased appetite/dysgeusia

25

18.2

0

0

Mucositis

35

25.5

2

1.5

Hypertension

59

43

4

2.9

Neutropenia

49

36

7

5.1

Anemia

51

37

8

5.8

Skin/hair discoloration

41

30

0

0

Dyspepsia

43

31.4

0

0

Thrombocytopenia

18

13.1

3

2.2

Hypothyroidism

42

31

2

1.5